Tandem Diabetes Care Inc
F:TD5A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tandem Diabetes Care Inc
F:TD5A
|
US |
|
S
|
SAGE Therapeutics Inc
F:SG7
|
US |
|
M
|
Mercury NZ Ltd
XBER:MRY
|
NZ |
Multiples-Based Value
The Multiples-Based Value for
Tandem Diabetes Care Inc (TD5A) under the Base Case is 22.92 EUR.
Compared with the current market price of 16.9 EUR, the stock appears
Undervalued by 26% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.